Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Boehringer Ingelheim discloses preclinical data on MAb targeting insulin-like growth factor I and II

Dec. 13, 2011

Mutant-selective inhibitor of epidermal growth factor receptor assessed in NSCLC

Dec. 13, 2011

Promising in vivo data presented on BI-853520

Dec. 13, 2011

S-44563 assessed in vivo in models of uveal melanoma

Dec. 13, 2011

ENGAGE-501 study evaluates entinostat in Hodgkin's lymphoma

Dec. 12, 2011

OZ-439 reduces parasitemia in proof-of-concept study

Dec. 12, 2011

Merz Pharmaceuticals NME shows antidyskinetic efficacy

Dec. 12, 2011

Two new allosteric nicotinic acetylcholine alpha4beta2 receptor modulators described

Dec. 12, 2011

New serine/threonine-protein kinase Chk1 inhibitor shows antitumor in vivo

Dec. 12, 2011

Genosco and Oscotec disclose promising therapeutics for acute myeloid leukemia

Dec. 12, 2011

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...